The Safety, Tolerability, PK, and PD of DWP213388 After SAD and MAD Administration in Healthy Adult Subjects
Clinical trial NCT05607589 · WITHDRAWN
Trial details
- NCT number
- NCT05607589
- Sponsor
- Daewoong Pharmaceutical Co. LTD.
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-10-01
- Primary completion
- 2024-02-20
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.